Svas Biosana SpA (SVSB)

Currency in EUR
9.18
+0.12(+1.32%)
Real-time Data·
Earnings results expected in 13 days
SVSB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.189.18
52 wk Range
7.3010.80
Key Statistics
Prev. Close
9.06
Open
9.18
Day's Range
9.18-9.18
52 wk Range
7.3-10.8
Volume
9
Average Volume (3m)
4.33K
1-Year Change
26.8908%
Book Value / Share
12.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SVSB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.90
Upside
+40.52%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in oncology, intensive care, chronic illnesses, and surgeries; and medical devices for use in radiology and diagnostic imaging, orthopaedics, cardiology, heart surgery, and critical care applications. SVAS Biosana S.p.A. was founded in 1972 and is based in Somma Vesuviana, Italy.

Employees
350
Market
Italy

Compare SVSB to Peers and Sector

Metrics to compare
SVSB
Peers
Sector
Relationship
P/E Ratio
7.1x12.5x−0.5x
PEG Ratio
-0.050.00
Price/Book
0.7x2.0x2.6x
Price / LTM Sales
0.4x1.3x3.2x
Upside (Analyst Target)
42.4%21.7%47.4%
Fair Value Upside
Unlock24.1%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.90
(+40.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
2.19%
Industry Median 1.49%
Annualised payout
0.20
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
21/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

3.220
CDGI
+0.31%
0.36
MSTN
-4.26%
3.1600
PLC
+3.95%
9.95
MGS
0.00%

FAQ

What Is the Svas Biosana (Milan: SVSB) Share Price Today?

The Svas Biosana stock price today is 9.18 EUR.

What Stock Exchange Does Svas Biosana (SVSB) Trade On?

Svas Biosana is listed and trades on the Milan Stock Exchange.

What Is the Ticker (Stock Symbol) for Svas Biosana?

The stock symbol (also called a 'ticker') for Svas Biosana is "SVSB."

Does Svas Biosana Pay Dividends? What’s The Current SVSB Dividend Yield?

Yes, SVSB Pays Dividends to its Shareholders. The current Svas Biosana dividend yield is 2.19%.

What Is the Current Svas Biosana Market Capitalisation?

As of today, Svas Biosana (Milan: SVSB) market cap is 48.14M EUR.

When Is the Next Svas Biosana Earnings Date?

Svas Biosana's next earnings report will be released on 11/05/2026.

Is SVSB a Buy or Sell From a Technical Analyst Perspective?

Based on today's Svas Biosana moving averages and other technical indicators, the daily buy/sell signal for SVSB stock is Strong Buy.

How Many Times Has Svas Biosana Stock Split?

Svas Biosana has split 0 times. (See the SVSB stock split history page for full effective split date and price information.)

How Many Employees Does Svas Biosana Have?

Svas Biosana has 350 employees, based on their latest Companies House report.

What is the current trading status of Svas Biosana (Milan: SVSB)?

As of 28/04/2026, Svas Biosana (SVSB) is trading at a share price of 9.18 EUR, with a previous close of 9.06 EUR. The stock has fluctuated within a day range of 9.18 EUR to 9.18 EUR, while its 52-week range spans from 7.30 EUR to 10.80 EUR.

What Is Svas Biosana (SVSB) Price Target According to Analysts?

The average 12-month price target for Svas Biosana is 12.90 EUR, with a high estimate of 12.9 EUR and a low estimate of 12.9 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +40.52% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.